Penserra Capital Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,597
| Closed | -$14K | – | 1075 |
|
|
2022
Q2 | $14K | Buy |
3,597
+666
| +23% | +$2.59K | ﹤0.01% | 1176 |
|
|
2022
Q1 | $16K | Sell |
2,931
-961
| -25% | -$5.25K | ﹤0.01% | 1312 |
|
|
2021
Q4 | $33K | Sell |
3,892
-2,917
| -43% | -$24.7K | ﹤0.01% | 1128 |
|
|
2021
Q3 | $59K | Sell |
6,809
-4,989
| -42% | -$43.2K | ﹤0.01% | 1001 |
|
|
2021
Q2 | $124K | Sell |
11,798
-4,728
| -29% | -$49.7K | ﹤0.01% | 744 |
|
|
2021
Q1 | $265K | Sell |
16,526
-5,578
| -25% | -$89.4K | ﹤0.01% | 545 |
|
|
2020
Q4 | $1.02M | Buy |
22,104
+19,280
| +683% | +$890K | 0.02% | 309 |
|
|
2020
Q3 | $106K | Buy |
+2,824
| New | +$106K | ﹤0.01% | 481 |
|